A progress in electroconvulsive therapy: the non-barbiturate anesthaetic drug etomidate.
Forty-six female patients (19-72 years) requiring ECT for psychiatric indications received 0.5 mg atropine, followed by 0.1-0.4 mg/kg bodyweight of etomidate. Subsequently 50 mg of suxamethonium were injected and ECT was applied. The etomidate-ECT combination proved very suitable and was well tolerated.
D000328:Adult; D000368:Aged; D001794:Blood Pressure / Q000187:drug effects; D004565:Electroconvulsive Therapy / Q000379:methods*; D005045:Etomidate / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D008875:Middle Aged
D007093:Imidazoles; D005045:Etomidate